Nectin-4-directed Antibodies
DBCAT005663Pharmacologic class
Monoclonal antibodies directed towards nectin-4. A DrugBank category of 1 drug. 1 of them is approved.
- Also known as
- Nectin-4-directed mAbs
- Drugs
What you can answer from here — as of November 29, 2022
Which targets do Nectin-4-directed Antibodies share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account